Why Data Integrity Is the FDA's Top Priority
Data integrity has been the single most cited deficiency in FDA warning letters to pharmaceutical manufacturers since 2015. Between 2020 and 2025, over 60% of FDA warning letters to pharmaceutical manufacturers included data integrity findings. The consequences range from warning letters to import alerts, consent decrees, and criminal prosecution.
The core issue is straightforward: if regulators cannot trust the data, they cannot trust the product. And if they cannot trust the product, it cannot reach patients.
ALCOA+ Principles
The pharmaceutical industry has adopted the ALCOA+ framework as the standard for data integrity. Every data point in a GMP system must be:
| Principle | Meaning | ERP Implementation |
|---|---|---|
| **A**ttributable | Traceable to the person who generated it | User authentication and electronic signatures |
| **L**egible | Readable and permanent | Structured data fields with validated formats |
| **C**ontemporaneous | Recorded at the time of activity | Timestamp enforcement with server-synchronized clocks |
| **O**riginal | First-captured data or a certified copy | Original electronic record with controlled copy procedures |
| **A**ccurate | Error-free and reflective of the actual event | Input validation, range checks, and verification workflows |
| **+C**omplete | All data including repeat tests and OOS results | System prevents deletion; all results retained |
| **+C**onsistent | Chronologically logical; timestamps in sequence | Automatic timestamp sequencing enforcement |
| **+E**nduring | Maintained for the entire retention period | Validated backup, archive, and retrieval procedures |
| **+A**vailable | Retrievable throughout the retention period | Indexed storage with rapid search and retrieval |
How Pharmaceutical ERP Implements Data Integrity
Audit Trail Architecture
A pharmaceutical ERP like FlowSense implements audit trails as a fundamental system layer, not an optional feature.
Every record change is captured. The audit trail records the previous value, new value, user identity, timestamp, and reason for change. This applies to master data, transactional data, configuration settings, and user administration.
Audit trails cannot be disabled. Unlike some systems where administrators can turn off audit logging, a pharma-grade ERP makes audit trail capture a non-configurable architectural requirement.
Audit trails cannot be modified. The audit log is append-only. No user, including system administrators, can edit or delete audit trail entries.
Audit trails are reviewed. The system provides tools for periodic audit trail review, flagging unusual patterns such as frequent modifications, after-hours changes, or changes by unauthorized users.
User Management and Access Control
- Individual user accounts with unique credentials --- shared accounts are prohibited
- Role-based access control mapping job functions to system permissions
- Automatic session timeout after configurable periods of inactivity
- Password policies enforcing complexity, expiration, and reuse restrictions
- Account lockout after failed login attempts
- Access review workflows for periodic recertification of user permissions
Electronic Signature Controls
- Signature manifestation displaying the signer's name, date/time, and meaning of the signature
- Non-repudiation ensuring signers cannot deny they signed a record
- Sequential enforcement preventing approval before review, or release before approval
- Biometric or two-factor options for high-risk signing events
Data Lifecycle Management
- Validated backup procedures with tested recovery to ensure data endurance
- Archive management migrating older data to long-term storage while maintaining accessibility
- Retention period enforcement preventing premature deletion of GMP records
- Format migration ensuring archived data remains readable as technology evolves
Common Data Integrity Failures to Avoid
Shared user accounts. When multiple operators use a single login, audit trail attributability is destroyed. The ERP must enforce individual accounts with no exceptions.
Unofficial records. Data recorded on scratch paper, personal notebooks, or unofficial spreadsheets before being entered into the official system violates contemporaneous recording requirements.
Selective reporting. Deleting or hiding failed test results while reporting only passing results is a serious data integrity violation. The ERP must retain all data including invalidated results.
Clock manipulation. Changing system clocks to backdate entries undermines the entire audit trail. Synchronize all systems to a secured NTP server and restrict clock change permissions.
Building a Data Integrity Culture
Technology alone does not solve data integrity. Organizations must:
- 1Train every employee on ALCOA+ principles and their practical application
- 2Encourage error reporting without punitive consequences
- 3Perform regular self-inspections focused on data integrity indicators
- 4Review audit trails systematically as part of quality management
- 5Investigate anomalies promptly before they become systemic
Strengthen your data integrity posture with FlowSense. Request a data integrity assessment from our pharma ERP team.
